Nuvaira Stock

Develops devices for treating lung diseases

Sign up today and learn more about Nuvaira Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Nuvaira Stock

Nuvaira, Inc. (formerly Holaira, Inc.), located in Minneapolis, Minnesota is a privately held lung denervation company developing minimally invasive products that aims to make breathing easier for patients suffering from obstructive lung diseases.

Funding History

September 2010$3.0M
May 2011$5.0M
September 2012$10.6M
February 2013$10.0M
April 2014$40.0M
February 2019$79.0M


President and CEO

Dennis Wahr

Founder & CTO

Martin L. Mayse

Director of Regulatory Affairs

Mahtab Fatemi

Vice President Clinical Affairs

Jim Pavliska


Kari Kubesh

Senior Vice President Operations

Steve Mertens

Board of Directors, President and CEO

Dennis W. Wahr

Vice President International Development

Scott Grant


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: